Taysha gene therapies to participate in upcoming may investor healthcare conferences

Dallas--(business wire)--taysha gene therapies, inc. (nasdaq: tsha), a patient-centric, clinical-stage gene therapy company focused on developing and commercializing aav-based gene therapies for the treatment of monogenic diseases of the central nervous system (cns) in both rare and large patient populations, today announced its participation in a virtual fireside chat at the 2021 rbc capital markets global healthcare conference and a virtual presentation at the oppenheimer rare & orphan di
TSHA Ratings Summary
TSHA Quant Ranking